drugset / Trial / NCT02072200

Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)

NCT02072200

Phase 4 Completed 147 enrolled Mundipharma Korea Ltd
NaSingle-groupOpen-labelTreatment

Summary

This study is multicenter, Ph IV, single arm, interventional study to assess relative reduction of morning stiffness of Lodotra® in Rheumatoid Arthritis patients.Study medication will start after study visit at baseline (week 0, visit 1) and follow-up visit will be after 2, 6 and 12 weeks after treatment (visit 2,3,4).

Timeline

Start
2013-09
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisone Other / unclassified 10 mg Oral

Indications